Cosmo Pharmaceuticals N.V.
Symbole: COPN.SW
SIX
71.4
CHFPrix du marché aujourd'hui
1009.1513
Ratio P/E
14.6994
Ratio PEG
1.15B
Cap MRK
- 0.01%
Rendement DIV
Cosmo Pharmaceuticals N.V. (COPN-SW) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 50.3 | 241 | 222.2 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 55.1 | 23.6 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 28.5 | 38.6 | 24.5 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 14.2 | 11.5 | 13.1 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 9.3 | 53.6 | 39.7 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 102.2 | 306.1 | 275.8 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 28.6 | 30.3 | 30.5 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 24 | 24 | 24 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 355.6 | 366.8 | 372.7 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 379.6 | 390.8 | 396.7 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 3.3 | -46.9 | 25.4 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 14.7 | 18.6 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 40.3 | 64.5 | 58.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 451.8 | 453.5 | 529.7 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 554 | 759.6 | 805.6 | ||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 8.8 | 10.7 | 11.6 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 171.8 | 0.9 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 2.7 | 3.6 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0.9 | 1.8 | 169 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0.5 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 14.3 | 12.5 | 3.2 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 97.2 | 100.9 | 271.6 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1.3 | 2 | 2.6 | ||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 120.3 | 295.8 | 292.9 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 11.5 | 18.4 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 4.6 | 4.6 | 4.6 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 302.6 | 262.2 | 293.3 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -22.7 | -11.5 | -18.4 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 142.3 | 190.1 | 207.4 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 426.8 | 456.9 | 505.3 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 554 | 759.6 | 805.6 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 6.9 | 6.9 | 7.4 | ||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 433.6 | 463.8 | 512.7 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | 3.3 | 8.3 | 49.1 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 1.1 | 173.6 | 169.9 | ||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -49.2 | -12.2 | -28.6 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 24.5 | 24 | -6.9 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.9 | 7.4 | 6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -21.4 | 5.9 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.1 | 1.5 | 9 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -13.3 | -5.1 | -5.1 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -14.2 | 3.3 | -7.9 | |||||||||||||||||||
cash-flows.row.inventory | 0 | 1.6 | -6.1 | 0.4 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 14.2 | -3.3 | 7.9 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -14.9 | 1 | -5.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 6.1 | 6.2 | 4.2 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7.3 | -8.5 | -8.1 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 23.3 | -4.1 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -54 | -1 | -20 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 35.9 | 7.7 | 131.6 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 27.1 | 3.3 | -23.9 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 1.7 | 24.9 | 75.4 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -0.9 | -2.6 | -1.8 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.3 | 0.8 | 5.3 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -24.7 | -19.7 | -11 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -15.6 | -0.8 | 0 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -5.1 | -4.9 | -4.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -46.1 | -27.2 | -11.9 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.5 | 2.4 | -1 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -12.7 | 12.6 | 75.5 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 185.8 | 198.6 | 185.9 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 198.6 | 185.9 | 110.4 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 33.2 | 12.6 | 13 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7.3 | -8.5 | -8.1 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 25.9 | 4.1 | 4.9 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 96.7 | 102.1 | 65.1 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 39.3 | 18.8 | 15.1 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 57.4 | 83.3 | 49.9 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 51.7 | 36 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 45.3 | 55.3 | 38.8 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 84.7 | 74 | 54 | ||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 4.5 | 2.9 | 3.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 9.2 | 9 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -4.6 | -3.6 | -9.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 51.7 | 36 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -4.6 | -3.6 | -9.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 9.2 | 9 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 13.6 | 19.4 | 7.4 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 12.2 | 28.1 | 33.1 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 7.6 | 24.5 | 24 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 6.3 | 7 | 2.3 | ||||||||||||||||||||
income-statement-row.row.net-income | 0 | 1.1 | 17.2 | 21.7 |
Questions fréquemment posées
Quel est le total de Cosmo Pharmaceuticals N.V. (COPN.SW) de l'actif total?
Cosmo Pharmaceuticals N.V. (COPN.SW) Le total des actifs est 553980000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.593.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 1.901.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.012.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.126.
Qu'est-ce que Cosmo Pharmaceuticals N.V. (COPN.SW) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 1147000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 1079000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 45314000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.